Kukaa Salama (Staying Safe) : study protocol for a pre/post-trial of an interactive mHealth intervention for increasing COVID-19 prevention practices with urban refugee youth in Kampala, Uganda

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

INTRODUCTION: With over 82.4 million forcibly displaced persons worldwide, there remains an urgent need to better describe culturally, contextually and age-tailored strategies for preventing COVID-19 in humanitarian contexts. Knowledge gaps are particularly pronounced for urban refugees who experience poverty, overcrowded living conditions and poor sanitation access that constrain the ability to practise COVID-19 mitigation strategies such as physical distancing and frequent hand washing. With over 1.4 million refugees, Uganda is sub-Saharan Africa's largest refugee hosting nation. More than 90 000 of Uganda's refugees live in Kampala, most in informal settlements, and 27% are aged 15-24 years old. There is an urgent need for tailored COVID-19 responses with urban refugee adolescents and youth. This study aims to evaluate the effectiveness of an 8-week interactive informational mobile health intervention on COVID-19 prevention practices among refugee and displaced youth aged 16-24 years in Kampala, Uganda.

METHODS AND ANALYSIS: We will conduct a pre-test/post-test study nested within a larger cluster randomised trial. Approximately 385 youth participants will be enrolled and followed for 6 months. Data will be collected at three time points: before the intervention (time 1); immediately after the intervention (time 2) and at 16-week follow-up (time 3). The primary outcome (self-efficacy to practise COVID-19 prevention measures) and secondary outcomes (COVID-19 risk awareness, attitudes, norms and self-regulation practices; depression; sexual and reproductive health practices; food and water security; COVID-19 vaccine acceptability) will be evaluated using descriptive statistics and regression analyses.

ETHICS AND DISSEMINATION: This study has been approved by the University of Toronto Research Ethics Board, the Mildmay Uganda Research Ethics Committee, and the Uganda National Council for Science & Technology. The results will be published in peer-reviewed journals, and findings communicated through reports and conference presentations.

TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registry (NCT04631367).

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

BMJ open - 11(2021), 11 vom: 22. Nov., Seite e055530

Sprache:

Englisch

Beteiligte Personen:

Logie, Carmen H [VerfasserIn]
Okumu, Moses [VerfasserIn]
Berry, Isha [VerfasserIn]
Hakiza, Robert [VerfasserIn]
Kibuuka Musoke, Daniel [VerfasserIn]
Kyambadde, Peter [VerfasserIn]
Mwima, Simon [VerfasserIn]
Lester, Richard T [VerfasserIn]
Perez-Brumer, Amaya G [VerfasserIn]
Baral, Stefan [VerfasserIn]
Mbuagbaw, Lawrence [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
COVID-19 Vaccines
Clinical Trial Protocol
Journal Article
Preventive medicine
Public health
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 03.12.2021

Date Revised 16.12.2022

published: Electronic

ClinicalTrials.gov: NCT04631367

Citation Status MEDLINE

doi:

10.1136/bmjopen-2021-055530

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM333475070